Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography
Not Applicable
Completed
- Conditions
- IUCD Complication
- Interventions
- Registration Number
- NCT04505657
- Lead Sponsor
- Aswan University Hospital
- Brief Summary
our aims to investigate the effectiveness of10% Lidocaine Spray plus oral celecoxib for Pain Control During Hysterosalpingography
- Detailed Description
hysterosalpingography can cause pain and discomfort in several ways: Use of the tenaculum to grasp the cervix and straighten the uterus for proper insertion; trans-cervical actions including measuring uterine depth, inserting the cannula; and injection of the dye
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 150
Inclusion Criteria
- any patient came for Hysterosalpingography
Exclusion Criteria
- any patient has contraindication to Hysterosalpingography
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Celecoxib plus lidocaine celecoxib plus lidocaine Celecoxib 200 mg (Celebrex® 200, Pfizer,USA) administered orally 2 h before the procedure +10% lidocaine spray 4 puffs during the procedure Celecoxib Celecoxib Celecoxib 200 mg (Celebrex® 200, Pfizer,USA) administered orally 2 h before the procedure +Sterile water 4 puffs during the procedure lidocaine lidocaine placebo to celecoxib administered orally 2 h before the procedure +10% lidocaine spray 4 puffs during the procedure
- Primary Outcome Measures
Name Time Method Mean pain score during the procedure 10 minuets Assessment of pain using visual analog scale 0-10, 0 = minimum and 10 = maximum scores
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Aswan University Hospital
🇪🇬Aswan, Egypt